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FLEXIBLE MULTIFUNCTIONAL MOLECULAR VECTOR 
CONSTRUCTION FOR TESTING AFFINITY APPLICATIONS 
SUMMARY 
Biomolecules can be linked via peptide-protein constructs to any material with right 
functional domains recognizing the surface with high specifity. In our group, we 
selected and characterized different inorganic binding peptides for functional 
materials. These peptides can be utilized as moleculer linkers for many bio- and 
nano-technological applications. However, their applicability needs to be tested with 
the existing tags providing the high affinities.  
Here we aim to test our designed vector systems through expressing 6xHis-Tagged-
GFPuv protein coupled with a peptide linker. The same vector system is applied for 
quartz-binding peptide (QBP)-tagged GFPuv protein. 6xHis-tag, a common tagging 
used in the recovery of the peptides or proteins is compared to the engineered quartz 
binding peptide developed in a parallel study. Two developed constructs are going 
to be tested in terms of their binding affinities to their substrates Ni-NTA and Silica 
separately with the ease of GFPuv fluorescence under fluorescence microscopy.  
With the aim of expressing 6xHis-Tagged GFPuv protein we developed a DNA 
vector. Firstly, a 109-mer dsDNA with 6xHistidine and linker (6xHis-Linker) 
sequence was generated. The sequence contains the appropriate restriction enzyme 
sites and is cloned into TOPO-TA cloning vector. Secondly, restriction enzyme sites 
were generated at the N-terminus and C-terminus of GFPuv sequence with 
polymerase chain reaction (PCR). 6xHis-Linker sequence was then cloned into 
pETBlue-2 expression vector. Fusion of GFPuv sequence adjacent to 6xHis-liker is 
performed.  
The overall objective here is to generate a flexible vector system including 
restriction enzyme sites that is applicable for changing both 6xHis-tag and 
biofunctional protein parts to apply different inorganic binding peptides tagged with 
functional proteins.    
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AFĠNĠTE UYGULAMALARINI TEST ETMEYE YÖNELĠK DEĞĠġKEN 
ÇOK ĠġLEVLĠ MOLEKÜLER VEKTÖR TASARIMI 
ÖZET 
Biyomoleküller peptid-protein etkileşimleri ile doğru fonksiyonel yapılar kullanı-
larak her türlü materyal yüzeyine yüksek afinite ile bağlanabilir. Bizim çalışma 
grubumuzda işlevsel malzemeler için inorganiklere bağlanan çok farklı peptidler 
seçilip karakterize edilmiştir. Bu peptidler birçok biyo- ve nano-teknolojik 
uygulamalar için moleküler bağlayıcı olarak kullanılabilir. Ancak bu peptidlerin 
uygulanabilirliği yüksek afinite gösteren diğer var olan amino asit dizisinden oluşan 
işaret (“tag”) sistemleri ile karşılaştırılmalıdır.  
Burada bizim amacımız tasarladığımız vektör sistemi ile Histidin işaretli GFPuv 
proteinini aralarında bir bağlayıcı ile birlikte gen ifadesini sağlamaktır. Aynı vektör 
sistemi quartz bağlayıcı peptid (QBP) işaretli GFPuv protein için de uygulanmıştır. 
Yaygın olarak kullanılan bir yöntem olan histidin işaretleme ile protein izolasyon 
yöntemi parallel bir çalışma ile QBP işaretli protein izolasyon yöntemi ile 
karşılaştırılıyor. Amacımız iki izolasyon yönteminin GFPuv proteininin floresan 
mikroskobu altında ışıma yapmasından yararlanılarak substratları Ni-NTA ve 
Silika’ya olan bağlanma afinitelerinin karşılaştırılmasıdır.              
Histidin işaretli GFPuv proteininin gen ifadesini elde etmek için bir DNA vektörü 
tasarlandı. İlk olarak bağlayıcı ve 6xHistidin’den oluşan 109 bazlık iki zincirli DNA 
dizisi elde edildi. Dizi gerekli enzim kesim bölgelerini içerecek şekilde tasarlanmış 
olup TOPO-TA klonlama vektörüne sokuldu. İkinci olarak GFPuv dizisinin uç 
kısımlarında polimeraz zincir reaksiyonu vasıtasıyla enzim kesim bölgeleri 
oluşturuldu. Daha sonra 6xHis-Linker ve GFPuv dizileri yan yana olacak şekilde 
pETBlue-2 gen ifade vektörüne sokuldu.      
Buradaki genel amaç uygun enzim kesim bölgelerini de içeren değişken bir vektör 
sistemi oluşturarak hem Histidin işaretleyici kısmı hem de biyoişlevsel protein 
kısmını değiştirmeye uygun başka inorganic bağlayıcı peptid işaretleyicileri ve 
fonksiyonel proteinler için de uygulanabilir bir yöntem geliştirmektir. 
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1. INTRODUCTION 
1.1. Significance of Proteins in Biological Materials and Systems 
Proteins perform the vast majority of the biochemical processes that take place in or 
outside the cell. The imperative part of the biological structure and systems are 
proteins. Most of the biological processes such as cellular structure formation, 
catalization of biological reactions and controlling physical performance of 
biomaterials are consequently performed by proteins [1, 2]. As the main biological 
tissues, soft and hard tissues have very organized structure from molecular to 
nanoscale with very complex nano-architectures and infinite number of functional 
diversity which are formed by proteins [3, 4]. The most valuable parts of the tissues 
are composed of proteins by serving as transporters and self- and co-assembly into 
short and long range ordered substrates [5-8].       
Proteins are highly specific and selective towards their ligands that give them 
variable properties [9]. In order to control the structures and functions of biological 
systems proteins interact with other macromolecules [7]. While macromolecular 
interactions take place in soft tissues such as muscle and skin and [10], 
macromolecular-inorganic hybrids structure the basis of hard tissues [7, 11].  
At least one proteinaceous phase is included together with inorganic materials in 
hard tissues such as bones, dental tissues, shells, spicules, spines, skeletal units of 
single cell organisms or plants, bacterial thin film and nanoparticles. Binding of 
proteinaceous phase and organization of inorganic materials to perform protective 
layer formation, ion transferring and developing some optimal and mechanical 
properties are generated by specific inorganic binding proteins. The proteinaceous 
phase is mainly bound on the inorganic material which commonly includes magnetite 
(Fe3O4) particles in magnetotactic bacteria or teeth of chiton [12]; silica (SiO2) as 
skeletons of radiolarian [13] or tiny light-gathering lenses and optical wave guides in 
sponges [14]; hydroxyapatite (Ca2C(OH)3) in bones [15] and dental tissues of 
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mammals [16] and calcium carbonate (CaCO3) in the shells of mollusks [17] (Figure 
1.1). 
Each biosystem involves many proteins that may come into play spatially and 
temporally in a complex bio-scheme during the transport of species, synthesis, 
fabrication, system integration and networking as well as an inorganic material. 
Development of protocols for regeneration or emulation of the tissues, as well as 
novel hybrid materials and systems with unique physical properties would be 
possible with the understanding of the roles of proteins during biofabrication [18]. 
 
Figure 1.1: Examples of functional biological materials systems: (A) Magnetotactic 
bacteria, e.g. Aquaspirillum magnetotacticum, have aligned magnetite cubooctahedral-
shaped particles that are ordered single crystals. (B) The spicules of Rosella racovitzea have 
star-shaped tips that act as gatherers of light, which is pumped through the silica-based 
biological optical ﬁber to the interior of the sponge. (C) Nacre, mother-of-pearl, is a 
segmented laminated composite of calcium carbonate and biomolecules with excellent 
mechanical properties that provide an armor to mollusks such as the red abalone, Haliotis 
rufescens, shown here. (D) Mammalian enamel, such as from the mouse, is ~100% 
hydroxyapatite that has a hierarchically ordered woven structure to enable mastication under 
complex mechanical stresses (the right is an SEM image of the fractured surface and the left 
is a schematics of the woven architecture) [18]. 
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1.2. Hard Tissues and Inorganic Binding Proteins 
Hard tissues produced as biocomposites in many multicellular organisms such as 
bones, teeth,  shells,  skeletal  units  and  spicules are composed of not only minerals 
of different kinds, including hydroxyapatite, calcium and silica but  also  structural  
macromolecules  that  are  lipids,  proteins  and  polysaccharides. Inorganics can be 
synthesized by some of the bacteria and algae species. Some examples for these 
organisms are magnetotactic bacteria synthesizing magnetite; chrysophytes, diatoms 
and actinopoda synthesizing siliceous materials [8].  
Bioinorganics are synthesized by a coordinated process in multicellular organisms 
involving group of similar cells such as osteoblasts in bone [19] or dentinoblasts in 
dentin [20]. In these hard tissues the cells control the morphology, size and 
distribution of the hydroxyapatite mineral particles [21]. The resulting hard tissues 
are composites of particles within structural proteins. Serving as load-bearing 
systems with piezoelectric properties, dentin, enamel, and bone are known to be 
multifunctional. Similarly mantel cells synthesize hard tissues that are differentiated 
into much different architecture in shell-forming molluscan species. These 
allotrophic forms of calcium carbonate include layered, columnar, and foliated 
structures of crystalline units [8]. An Antarctic sponge Rozella racovitzea living 200 
m deep in the ocean has a symbiotic relation with green algae. Silica-based spicules 
composed of a spicular tip (a lens) and a shaft (optical fiber) function to collect and 
transmit the light. A layered and segmented hybrid composite of aragonite and a 
biopolymer mixture called nacre compose the interior of mollusks` shells [22]. 
Glycera being a marine bloodworm contains copper mineral in the teeth [23]. Hard 
tissues are normally mechanical devices (e.g. skeletal, cutting, and grinding) 
however they serve a physical function like magnetic, optical and piezoelectric. 
Dentin, enamel and bone, serving as load-bearing systems with piezoelectric 
properties, are multifunctional. Bioinorganics in hard tissues have vital importance 
for physiological activities as ion sources in the integral parts of the organisms [4, 
24].         
Raw materials are collected and transported as well as subunits are uniformly self-
assembled and co-assembled into short- and long-range ordered nuclei and substrates 
by organic macromolecules. The resulting structures are highly organized  from  the 
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molecular  to  the  nano, micro  and macroscales with  complex architectures  that  
each  hierarchical  manner  has  its  own  different  function [25]. However, their 
characteristics are difficult to achieve in purely synthetic systems since their 
organization and formation are self-directed; their interaction with their surroundings 
is dynamic; their structures, functions, self-healing in damage control are complex 
and their physical and chemical properties are multifunctional [18]. 
Polypeptides such as ice-binding (antifreeze) proteins that are synthesized in many 
fish species, plants and insects are known to be specifically binding to inorganics 
[18]. Other examples include amelogenins in mammalian enamel synthesis [26], 
calcite- and aragonite- forming polypeptides in mollusk shells [27] and silicatein in 
sponge spicular formation [28]. Silicateins (silica binding proteins) were extracted 
and characterized from needle like spicules of the sponge Tethya aurantia. Three 
subunits, α, β, and γ persist in the protein where α plays an important role in 
biosilification. These silica spicules support the organism and defense against 
predation [29].            
The silica-precipitating peptides namely silaffins were extracted from the cell wall of 
a diatom, Cylindrotheca fusiformis, which are unicellular algae present in marine and 
fresh water habitats. Biosilification proceeds at ambient temperatures and pressures 
in these organisms producing an amazing diversity of nanostructured frameworks. 
Components present within the diatom cell that control silica sphere formation 
suggest that silica is initially deposited in the form of nanoscale spheres. Organic 
substances associated with the amorphous silica in diatom cell walls are considered 
to have regulating properties in biosilification [30].  
Natural proteins that are extracted, purified and engineered from biological hard 
tissues are shown to preserve their biomaterialization abilities for silica formation 
[31]. Extraction from hard tissues is a complex and time consuming process with the 
traditional approach including protein isolation, purification, amino acid analysis and 
sequencing [8]. The difficulty of the process comes with the spatial and temporal 
distribution of the proteins in complex ways in given hard tissue. Determination of 
the key proteins involved in biomineralization is a lengthy and time consuming 
procedure. For instance there are more than 20 proteins implicated in the synthesis of 
human enamel and 10 proteins identified in mollusk shells [18].           
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1.3. Genetically Engineering Proteins for Inorganics (GEPI) 
A sequence of amino acids that specifically and selectively binds to an inorganic 
surface is defined as genetically engineered polypeptide for inorganics (GEPI). The 
surface could be a well defined single crystal or a nanostructure as well as rough or 
totally non-descriptive such as a powder. In many early studies powder samples were 
used however recent studies have focused on using materials that can be synthesized 
in aqueous environments under physiological conditions (biocompatible) and that 
exhibit fairly stable surface structures and compositions. Noble metals (Pt and Pd) 
and oxide semiconductors (Cu2O and ZnO) that were biopanned using either phage 
display or flagellar display might be given as examples [7].    
There are three unique advantages in developing future materials and systems with 
proteins: molecular recognition, self-assembly and genetic manipulation [22]. 
Quantitative binding experiments and modeling give some clues about the 
possibilities of the fundamental mechanism of the recognition of a material surface 
by a short peptide though it is not so clear [32]. Molecular recognition leads to 
nucleation, growth and morphogenesis of inorganics under favorable synthesis 
conditions and crystal-speciﬁc display of peptides. A peptide is capable of self-
arrange on the surface of a material to form supramolecular architectures prior to 
recognition [18].   
Proteins and peptides being coded by the genes (of bacteria, phage, and yeast) 
provide ways to genetically modify them and precisely engineer their practical 
functions. So it is a new advantageous genome-based manufacturing technology. 
With the polypeptides being tailored genetically, developing under this framework 
would provide a multidisciplinary platform towards realizing hybrid building blocks. 
The synthetic component is designed for its speciﬁc chemical and physical functions 
for a wide range of applications from materials science to medicine [22]. 
Proteins bind selectively to their ligands with complementarity in molecular 
architectures and surface chemistries [18]. By using inorganic materials exhibiting 
speciﬁc morphology, crystallography, or surface stereochemistry might be used to 
select inorganic-binding polypeptides. It is essential to understand the nature of 
polypeptide-inorganic recognition and binding in the design and assembly of 
functional inorganics for the optimization and tailor of these events. However, 
recognition of inorganics by proteins remains unclear [33]. Both chemical (e.g., H-
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bonding, polarity, and charge effects) and structural (size and morphology) 
recognition mechanisms might be involved in the speciﬁcity of a protein for a 
surface. In addition the inorganic surface properties must be well characterized to 
provide an understanding of the nature of binding [18].   
1.3.1. Chemical Specificity of Inorganic Binding 
It is generally assumed that with small molecules low-to-moderate energy adsorption 
on surfaces is reversible and is not surface sensitive. Besides moderate-to-high 
adsorption energy systems possess speciﬁc surface selectivity and undergo 
irreversible surface chemical bonding [34]. Chemical bonding of functional groups 
such as thiol-terminated molecules for noble metal surfaces or silanes for metal oxide 
surfaces result in adsorption selectivity [35, 36]. On the other hand these selectivities 
are not clear enough to understand the reversible and selective interaction of a 
polypeptide or protein with its target substrate. Combination of amino acid sequence 
(i.e., spatial arrangement) and the nature of diverse amino acid side-chain 
interactions might dictate to the interaction of a single polypeptide or protein in a 
complex manner. Briefly, it is hardly possible to foresee the correct combinations of 
spatial conﬁguration and choice among the 20 commonly occurring amino acids that 
reveal both selectivity and strong binding. However, the features of known 
inorganic-binding polypeptides and proteins provide valuable information about the 
roles of the surface, the amino acids and water [18].          
1.3.2. Physical specificity of Inorganic Binding 
The molecular structure of a polypeptide affects its specificity to an inorganic 
surface. Various sizes and morphologies of powders have been used for the selection 
of GEPI. In order to ease the attachment of peptides to surfaces with various 
morphological features the sequence space should be largest for powders. A GEPI 
may both bind to a material of a certain size and the smaller particle of the same 
material but at different affinities. Likewise a GEPI binding strongly to a specific 
crystallographic surface may bind with an altered affinity to another surface of the 
same material [7].      
In order to elucidate the fundamentals of the recognition process and practical 
applications it is essential to obtain structural information. This knowledge would 
lead to genetic or chemical modiﬁcations to create additional functionalities such as 
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attachment of conducting or light-emitting polymers to create hybrid, 
heterofunctional molecules; ability to bind DNA or proteins. It is possible to obtain 
an averaged lowest energy structure for as many GEPI as is feasible by using 
molecular dynamics and simulated annealing protocols and solution or solid-state 
NMR constraints. These structures could be used with a combination of simulation 
program in modeling the orientation and binding energetics at speciﬁc interfaces 
[18].  
1.4. Obtaining Inorganic Binding Peptides 
In order to obtain polypeptides or proteins specific to inorganics there exist several 
possible ways. Extracting the biomineralizing proteins from the hard tissues is one of 
the possibilities to obtain inorganic binding proteins [7, 18]. However, extraction of 
proteins and cloning of their genes might be complicated and time consuming. On 
the other hand there are limited well-characterized inorganic binding polypeptides 
that are known [37]. Also other macromolecules in multicellular and single celled 
organisms may affect biomineralization in addition to proteins that make the process 
more complex [38, 39]. Although the extraction is a laborious process, some proteins 
have been isolated and used in the synthesis of certain inorganics and growth 
modifiers such as amelogenins being used in mammalian enamel synthesis and 
silicatein being used in sponge specula formation [38, 40, and 41].     
Combinatorial biology techniques are amongst the most preferred approaches for 
obtaining inorganic binding polypeptides [42]. In this approach, there are 
combinatorial biology libraries which are used to select inorganic binding proteins 
against a specific inorganic material. These libraries consist of random peptides with 
the same number of amino acids but in different sequence compositions [7, 43, 44]. 
The desired specific polypeptide or single amino acid need not to be known at the 
beginning since the specific polypeptide is simply selected and enriched. For the 
isolation of polypeptides capable of binding to inorganic materials with high affinity 
there are two well established in vivo display techniques which are phage display 
(PD) [45, 46] and cell surface display (CSD) [47]. 
Phage display is a combinatorial biology technique mainly used in protein-ligand 
interactions and to extract engineered proteins with altered affinities which provides 
peptides with desired binding affinities to be selected from a large library of variants 
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[48]. In PD, the gene of interest is fused to the coat protein of a phage and the desired 
peptides are expressed on phage coat [22]. Similar to PD, in CSD outer membrane 
proteins, lipoproteins, fimbria and flagellar proteins have been used so far for 
heterologous surface display on bacteria [49]. The DNA of the phage or bacteria are 
sequenced and the proteins involved in binding to inorganics are determined (Figure 
1.3). Obtained molecular toolbox with GEPI is used with bioinformatics to design 
GEPIs computationally. Sequence  similarity  scores of GEPIs  can  be  developed de 
novo  for  the  desired  affinity  and specificity by using genetic algorithm procedures 
[22].  
 
Figure 1.2: Phage display and cell-surface display. Principles of the protocols used for 
selecting polypeptide sequences that have binding affinity to given inorganic substrates [7]. 
1.5. Molecular Biomimetics 
Hybrid materials could potentially be assembled from molecular level using the 
recognition properties of proteins which brings us a new field called molecular 
biomemetics where the physical and biological fields are combined. Here inorganic 
surface-specific polypeptides could be used as binding agents to control the 
organization and specific functions of materials (Figure 1.4). In order to develop 
hetero-functional nanostructures, molecular biomimetics concurrently offers three 
solutions. First solution is designing protein templates at the molecular level through 
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genetics. This DNA-based technology ensures complete control over the molecular 
structure of the protein template. As a second solution, synthetic entities, including 
nanoparticles, functional polymers, or other nanostructures are bound onto molecular 
templates    where surface-specific proteins can be used as linkers (molecular and 
nanoscale recognition). The third solution is that the formation of ordered 
nanostructures is formed by self- and co-assembly of biological molecules. This 
similar robust assembly process found in nature ensures achieving complex nano- 
and possibly hierarchical structures (self-assembly) [7]. 
 
 
Figure 1.3: Molecular biomimetics. In molecular biomimetics, inorganic-binding proteins 
could potentially be used as (i) linkers for nanoparticle immobilization; (ii) functional 
molecules assembled on specific substrates; and (iii) heterobifunctional linkers involving 
two (or more) binding proteins linking several nanoinorganic units. (I1: inorganic-1; I2: 
Inorganic-2; P1 and P2: inorganic specific proteins; LP: linker protein; FP: fusion protein) 
[7].    
1.6. Significance of Affinity Tags in Purification of Recombinant Proteins 
Recombinant proteins and native protein complexes are commonly purified by 
protein and peptide affinity tags for excellent reasons [50]. Proteins can be purified 
up to hundred- or even thousand-fold from crude extracts without prior steps to 
remove nucleic acid or other cellular material. Next, affinity tags are useful for 
purifying individual proteins and especially protein complexes in mild elution 
conditions. More importantly, in contrast to highly customized procedures associated 
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with conventional chromatography, affinity tags allow diverse proteins to be purified 
using generalized protocols [51].  
Most of the available protein and peptide affinity tags, which were developed within 
the last 20 years, can be categorized into three classes depending on the nature of the 
affinity tag and its target. Epitope affinity tags constitute the first class where peptide 
or protein fusion is used to bind to small molecule ligands linked to a solid support. 
For instance, the hexahistidine tag binds to immobilized metal [52] while glutathione 
S-transferase protein fusions bind to glutathione attached to chromatography resin 
[53]. In the second class of affinity tags, a protein-binding partner immobilized on 
chromatography resin is used to bind a peptide tag. Binding of calmodulin-binding 
peptide specifically to calmodulin might be given as an example where proteins 
fused to the peptide are allowed to be purified over calmodulin resin [54]. The third 
class of epitope affinity tags resembles the second class. Here the protein-binding 
partner attached to the resin is an antibody which recognizes a specific peptide 
epitope. The flag peptide which can be used with one of several anti-FLAG antibody 
resins can be given as an example [55].  
 
Figure 1.4: A. Interaction between Ni-NTA and a 6xHis-tagged protein [61] B. Purification 
of 6xHis-tagged proteins. 
His-tags are the most widely used affinity tags amongst several others. His-tagged 
protein purification is based on the use of chelated metal ions as affinity ligands. The 
metal ion is complexed with an immobilized chelating agent (immobilized metal-ion 
affinity chromatography, IMAC). Protein separation using IMAC is based on the 
interactions between certain aa residues and the metal ions within an immobilized 
metal chelate. These aa residues are mainly histidine [56] and the imidazole side 
chain of histidine shows high affinity for chelated metals [57]. The use of short 
histidine stretches or his-tags enables the purification of the desired protein from the 
crude extract of the host cells in a single step. These histidine stretches are typically 
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placed as affinity tags at either the N-terminus or C-terminus. Chromatographic 
supports and strategies available for IMAC differ. The most widely used IMAC 
supports are nitrilotriacetic acid (NTA) which serves as a ligand for immobilizing 
metals like nickel in affinity chromatography (Ni–NTA) or different chelating 
Sepharose matrices. Different metals have also been developed as alternatives [58]. 
The binding specificity is important in purification of proteins under both native and 
denaturing conditions [56]. The affinity of can be modulated by using His-tags of 
various lengths but generally His-tags are designed within the range of six to twelve 
consequtive histidines [58].  
NTA is a tetradentate chelating adsorbent that occupies four of the six ligand binding 
sites in the coordination sphere of the nickel ion, leaving two sites free to interact 
with the 6xHis tag (Figure 1.5). Binding of NTA to metal ions is far more stable than 
other available chelating resins [59]. NTA also retains the ions under a wide variety 
of conditions, especially under stringent wash conditions. The unique, patented NTA 
matrices can bind 6xHis-tagged proteins allowing the purification of proteins to more 
than 95% homogeneity in just one step [60].    
 
                                                                                                                                                                                                                        
 
Figure 1.5: A. Interaction between neighboring residues in the 6xHis tag and Ni-NTA 
matrix. B. Interactions of metal chelate matrices with nickel ions [61].  
B 
A 
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The use of his-tags and IMAC purification is not recommended for proteins 
containing metal ions even though they are universally applicable. Similarly, 
unwanted protein binding may occur during IMAC purification if other aa like 
cysteine and naturally occurring histidine rich regions in host proteins are used [62]. 
Numerous proteins and peptides have been purified using his-tags as well as several 
therapeutic candidates are in clinical studies since its development [63].   
1.7. Properties of Recombinant Green Fluorescent Protein (GFPuv) 
Green fluorescent protein (GFP), which is extracted from Aequorea victoria, has the 
ability to act as a fluorophore. It shows a maximum excitation under ultraviolet light 
(UV) in the interval of λ = 395–498 nm and emission in the interval of λ = 490–520 
nm, with the maximum peak at λ = 508–509 nm. The recombinant fluorescent green 
protein (GFPuv) was developed by introducing point mutations in an in vitro wild 
GFP DNA. Three amino acids (Phe
99
 for Ser; Met
153
 for Thr; and Val
163
 for Ala, 
based on the amino acid numbering of wild gfp) were replaced and expressed by 
transformed (pGFP, Clontech) cells of Escherichia coli. GFPuv is expressed two to 
three times faster in E. coli and exhibits eighteen-fold greater fluorescence intensity 
than native GFP. The maximum peaks for fluorophore excitation are at 395 nm and 
centered at 508–509 nm for emission [64].  
The recombinant GFPuv is made up of 27 kDa monomers (with 238 amino acids). It 
is a compact and acidic globular protein with a propensity to dimerize. The protein 
fluorescence is optimum at pH 8.0 and stable between pH 5.5 and 11.5. The protein 
must be in proper conformation to provide fluorescence. The fluorescence 
characteristics of GFPuv can be quantified by a variety of techniques using 
fluorescence microscopy, flow cytometry and spectro-fluorometry [65]. 
1.8. The pET Expression System  
Expression systems are designed to produce many copies of a desired protein within 
a host cell. The expression of the construct in pET system is under the control of T7 
promoter. Unlike E. coli enzyme T7 RNA polymerase is a single-subunit enzyme 
that binds to distinct DNA promoter sequences found upstream of the T7 viral gene it 
activates. T7 promoter sequences are not recognized by E. coli RNA polymerase as 
start sites for transcription [66] (Figure 1.6).   
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A plasmid expression vector is used to clone the target gene under the control of T7 
promoter. However, expression of the target gene in wild-type E. coli cells will not 
produce any results because the T7 RNA polymerase is absent. Therefore the 
expression plasmid is transformed into an E. coli strain that contains a copy of T7 
gene 1 under the control of the lac promoter to obtain target gene expression. This is 
achieved by using E. coli strains bearing a λ lysogen called DE3 that contains the T7 
RNA polymerase gene under the control of the lacUV5 promoter. Consequently 
expression of the target gene will be driven by IPTG induction and promote the 
synthesis of T7 RNA polymerase which will bind to the T7 promoter. Even in the 
absence of inducer the lac promoter will express small amounts of the gene it 
controls. The level of the target gene expression is reduced by addition of a laco 
sequence in between the T7 promoter and the target gene in the expression vector 
[67].  
 
 
Figure.1.6. Control Elements of the pET System: Illustrated here are the host and vector 
elements that are available for control of T7 RNA polymerase levels and subsequent 
transcription of a target gene cloned in a pET vector.  In  λ  DE3  lysogens, the T7 RNA 
polymerase gene is  under control of  the lacUV5 promoter, which allows  low  levels of  
transcription in  the uninduced  state. For more stringent control of expression, hosts carrying 
either pLysS or pLysE are available. The pLys plasmids encode T7 lysozyme, a natural 
inhibitor of T7 RNA polymerase, and thus reduce its ability to transcribe target genes in 
uninduced cells. (Redrawn, with permission, from Novagen, Inc) [68, 69].  
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E. coli cells can be co-transformed with an additional plasmid to control the leaky 
production of T7 RNA polymerase. Thus the target gene expression is minimized. As 
shown in figure 1.6 the plasmid pLysS will produce T7 lyzozyme which is a natural 
inhibitor of T7 RNA polymerase. This plasmid uses a different but compatible 
replication origin to the expression vector [69]. In the absence of induction, the 
production of this inhibitor will inactivate the small levels of polymerase produced. 
However it will be flooded and thereby rendered ineffective by the larger amounts of 
polymerase produced during induction. Many proteins cannot be produced in E. coli 
cells even though the availability of excellent promoters that will drive high levels of 
RNA production. Promoter strength is not necessarily the determining factor as to 
levels at which the target protein will accumulate within the cell [68]. 
pETBlue-2 expression vector is a derivative of pET vectors (See Appendix A). 
Unlike other T7lac promoter-based pET vectors, pETBlue plasmids do not contain 
the lac repressor gene and therefore additional lac repressor is required. pETBlue 
recombinants identified and isolated from the blue/white screening can be 
transformed into specialized (DE3)pLacI expression hosts for IPTG-based induction. 
These hosts carry a chromosomal copy of T7 RNA polymerase under the control of 
the lacUV5 promoter and supply sufficient lac repressor from the compatible pLacI 
plasmid to ensure stringent repression in the uninduced state. pLacI encodes the lacI 
gene and chloramphenicol resistance marker on a plasmid that is compatible with 
pETBlue [70]. 
1.9. Aim of the Study 
In this study, our aim is to test our designed vector systems in an ongoing project  
through expressing His6-Tagged GFPuv protein coupled with a peptide linker. The 
same vector system is applied for quartz-binding peptide (QBP)-tagged GFPuv 
protein. His6-tag, a common tagging used in the recovery of the peptides or proteins, 
will be compared to the engineered quartz binding peptide (QBP-1) developed in a 
parallel study. Two developed constructs will be tested in terms of their binding 
affinities to their substrates Ni-NTA and Silica, respectively with the ease of GFPuv 
bioluminesence property under fluorescence microscopy.   
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Bacterial Strains  
2.1.1.1. E. coli DH5
TM
-T1
R
 host strain 
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 λ- thi-1 gyrA96 relA1 tonA, chemically competent cells were  
supplied with Gene-Tailor
TM
 Site-Directed Mutagenesis System (Catalog#12297-
016, Invitrogen). 
2.1.1.2. E. coli Tuner
TM
(DE3)pLacI host strain 
F- ompT hsdSB (rB
-
 mB
-
) gal dcm lacY1 (DE3) pLacI (Cm
R
), chemically competent 
cells compatible with expression from pETBlue
TM
 vectors, were supplied with 
pETBlue™ System (Catalog#70674-3, Novagen).  
2.1.1.3 E. coli One Shot
®
 TOP10 host strain 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara-
leu)7697 galU galK rpsL (Str
R
) endA1 nupG, electrocompetent and chemically 
competent cells were supplied with One Shot
®
 TOP10 Competent Cells (Catalog# 
C4040-52, Invitrogen) 
2.1.2. Cloning Vectors 
2.1.2.1. PETBlue-2 Expression Vector 
The pETBlue™ vectors are designed to identify recombinants by traditional 
blue/white screening while also allowing T7lac promoter based expression of target 
genes. pETBlue-2 vector (See Appendix A) was purchased from Novagen 
(Catalog#70674-3, EMD Biosciences, Inc.). 
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2.1.2.2. pCR
®
2.1-TOPO
®
 Cloning Vector 
pCR
®
2.1-TOPO
®
 cloning vector (See Appendix-B) was purchased from 
Invitrogen
TM
 (Catalog#K4560-40) to be used for cloning of PCR products containing 
the single A (Adenine) overhang at each end. Adenine nucleotide was added at 3’ 
ends of blunt-ended PCR products using QIAGEN A-Addition Kit (Catalog# 
231994, Qiagen).  
2.1.3. Enzymes 
2.1.3.1. Restriction Enzymes  
EcoRI (G^AATTC, Fermentas), PstI (CTGCA^G, Fermentas), BglII (A^GATCT, 
Fermentas) and NcoI (C^CATGG, Fermentas) restriction endonucleases and their 
reaction buffers were obtained from Fermentas (Catalog #ER0611, ER0081). 
2.1.3.2. Taq DNA Polymerase  
The Taq DNA Polymerase is a highly thermostable DNA polymerase that catalyzes 
template-dependent polymerization of nucleotides into duplex DNA in the 5'=>3' 
direction. The Taq DNA Polymerase possesses low 5'=>3' exonuclease activity and 
has no detectable 3'=>5' exonuclease (proofreading) activity. Like other DNA 
polymerases without 3'=>5' exonuclease activity, Taq DNA Polymerase exhibits 
deoxynucleotidyl transferase activity, which frequently results in the addition of 
extra adenines at the 3'-end of PCR products (Catalog # EP0402, Fermentas). 
2.1.3.3. Pfu DNA Polymerase 
The Pfu DNA Polymerase is a highly thermostable DNA polymerase that catalyzes 
the template-dependent polymerization of nucleotides into duplex DNA in the 5'=>3' 
direction. The Pfu DNA Polymerase also exhibits 3'=>5' exonuclease (proofreading) 
activity, that enables the polymerase to correct nucleotide incorporation errors. The 
enzyme has no 5'=>3' exonuclease activity (Catalog#EP0502, Fermentas). 
2.1.3.4. Quick T4 DNA Ligase 
Quick T4 DNA ligase was supplied with Quick Ligation
TM
 Kit purchased from New 
England Biolabs, Inc (Catalog # M2200S). 
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2.1.4. DNA Molecular Weight Markers  
DNA molecular weight standard markers (See Appendix C) were obtained from MBI 
Fermentas. 
2.1.5. Oligonuclotides 
Oligonucleotides given below were synthesised by Alpha DNA on automated 
computer-controlled synthesizers using standard phosphoramidite chemistry. The 
oligonucleotides were purchased as lyophilized form. 
6His-Linker      5’-GCTGACGTTGGAAGATCTTCAAGGAGATAT 
ACCATGCATCACCATCACCATCACGGATCCCCGCCG 
CCGGGCCCGCCGGGCCCGCCGCCGGGCCCGCCGCCG
ATTGAAGGCCGTGGAATTCCAT GGCATCG -3’ 
Forward Primer  5’- GCTGACGTTGGAAGATCTTCAAGGAGA -3’ 
Reverse Primer  5’- CGATGCCATGGAATTCCACGGCCTTCA -3’ 
M13 (-20) Forward     5´- GTAAAACGACGGCCAG -3´ 
pETBlue-2 Up Primer 5’- TCACGACGTTGTAAAACGAC -3’ 
pETBlue-2 Down Primer 5’-AGTTAAATTGCTAACGCAGTCA -3’ 
GFPuv Forward Primer 5’AGCGAGAGATCTTCAAGGAGATATACCATGG 
   CGCATCACCATC -3’ 
GFPuv Reverse Primer 5’-AGATATACCATGGCGCATCACCATC -3’ 
2.1.6. Bacterial Culture Media 
2.1.6.1. LB (Luria-Bertani) Media 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water up to 1lt and the pH was adjusted to 7.0-7.5 with 10 
M NaOH and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.6.2. LB Agar Medium 
10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g bactoagar (Acumedia) were dissolved 
in distilled water up to 1 lt and the pH was adjusted to 7.0-7.5 with 10 M NaOH and 
sterilized by autoclaving. 
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2.1.6.3. SOC Medium 
20 g tryptone, 5 g yeast extract, 0.5 g NaCl was dissolved in 950 mL deionized 
water. 10 mL of 250 mM KCl was added and pH was adjusted to 7.0 with NaOH. 
Water was added up to 1lt and sterilized by autoclaving. Just before use, 10mM of 
MgCl2 and 20mM of glucose were added.  
2.1.7. Stock Solutions 
2.1.7.1. Ampicillin Stock 
100 mg/ml ampicillin sodium salt was dissolved in deionized water, filter-sterilized 
and stored in dark at -20°C. 
2.1.7.2. Chloramphenicol Stock 
34 mg/mL chloramphenicol was dissolved in 100% ethanol, filter-sterilized and 
stored at -20°C.  
2.1.7.3. Xgal / IPTG Stock 
1.25 g IPTG (Sigma) and 1 g Xgal (Fermentas) were dissolved in 25 mL DMF 
(Riedel-de-Haen). The solution was stored at –20°C in the dark. 
2.1.7.4. Glycerol Stock Solution 
50 mL glycerol (Riedel-de-Haen) and 50 mL distilled water were mixed to make 50 
% glycerol (w / v). It was sterilized for 15 minutes under 1.5 atm at 121°C. 
2.1.8. Buffers 
2.1.8.1. Na-Ac Buffer 
3 M of Na-Ac (Riedel-de-Haen) was dissolved in 75 mL distilled water. pH was 
adjusted to 4.6 and distilled water was added up to 100 mL. 
2.1.8.2. 10 X TBE Buffer (1000mL) 
108 g. of Tris base, 55 g. boric acid, and 40 mL 0.5 M EDTA at pH 8.0 were 
dissolved in 1 liter deionized water and sterilized for 15 min. under 1.5 atm at 121°C. 
 
  
19 
2.1.8.3. 1 M CaCl2 Solution (100mL) 
14.7 gr. CaCl2·2H2O was dissolved in 100 mL H2O and sterilized with 0.22 µ filter.  
2.1.8.4. 0.1 M CaCl2 in 15% Glycerol (100mL) 
Sterile 10 mL CaCl2, 30 mL 50% Glycerol and 60 mL dH2O were mixed.  
2.1.9. Lab Equipments 
Autoclave     : NuveOT 4060 vertical steam sterilizer, Nuve. 
Centrifuge     : Microfuge 18, Beckman Coulter. 
Centrifuge rotor    : F241.5P, Beckman Coulter. 
Deep freezes and refrigerators  : Heto Polar Bear 4410 ultra freezer, JOUAN 
: Nordic A/S, catalog# 003431. 
: 2021 D deep freezer, Arcelik. 
: 1061 M refrigerator, Arcelik. 
Electrophoresis equipments  : E-C Mini Cell Primo EC320, E-C Apparatus. 
: Mini-PROTEAN 3 Cell and Single-Row 
AnyGel Stand, Catalog# 165-3321,Bio-Rad. 
: Mini-V 8.10 Vertical Gel Electrophoresis 
System, Life Technologies GibcoBrl (now 
Invitrogen), Catalog# 21078. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited. 
Ice Machine     : AF 10, Scotsman. 
Incubators     : EN400, Nuve. 
Orbital shaker    : Certomat S II, product# 886 252 4, B. Braun 
Biotech International GmbH. 
Magnetic stirrer    : AGE 10.0164, VELP Scientifica srl. 
: ARE 10.0162, VELP Scientifica srl. 
Pipettes     : Pipetteman P10, P 100, P1000, Eppendorf 
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pH meter     : MP 220, Mettler Toledo International Inc. 
: Inolab pH level 1, order# 1A10-1113, 
Wissenschaftlich-Technische Werkstätten 
GmbH & Co KG. 
Power supply    : EC 250-90, E-C Apparatus. 
Pure water systems    : USF Elga UHQ-PS-MK3, Elga Labwater. 
Spectrophotometer    : DU530 Life Science UV/ Vis, Beckman. 
: UV-1601, Shimadzu Corporation. 
Vortexing machine    : Reax Top, product# 541-10000, Heidolph2.2. 
 
2.2. Methods 
2.2.1. Construction of 6xHis-Linker Oligonucleotide 
An oligonucleotide containing Ribosome Binding Site (RBS), 6xHis-tag, spacer and 
Factor Xa was designed. The oligonucleotide is 131 bases and includes restriction 
endonucleases BglII and EcoRI nearer the ends and BamHI between 6xHis tag and 
spacer. Forward and reverse primers were designed in order to amplify and obtain 
double-stranded form of the olinucleotide by Polymerase Chain Reaction (PCR). The 
primers and oligonucleotide were synthesized and obtained from Alpha DNA, 
Montreal (Quebec). The gene product 6xHis-Linker obtained from PCR is ligated 
into pCR2.1-TOPO cloning vector and transformed into E. coli One Shot TOP10 
chemically competent cells. Obtained vector constructs were sequenced in order to 
verify if the desired gene was inserted. 6xHis-Linker was digested from pCR2.1-
TOPO vector with BglII and EcoRI restriction enzymes and ligated into pETBlue-2 
expression vector respectively. The ligation product is transformed into E. coli Tuner 
(DE3) pLacI chemically competent cells. Each step is discussed below in detail. 
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2.2.1.1 Synthesis of Double Stranded DNA from an Oligonucleotide 
Polymerase chain reaction (PCR) was obtained with forward and reverse primers in 
order to obtain double-stranded DNA from the synthesized 6xHis-Linker 
oligonucleotide. Reaction conditions are described below: 
 Polymerase Chain Reaction (PCR) 
Template DNA (6xHis-Linker Oligo) : 0.5 µl (40 pmol) 
Forward Primer    : 1 µl (10 pmol) 
Reverse Primer    : 1 µl (10 pmol) 
dNTP (10mM each)    : 2 µl 
Taq Buffer (10X)    : 5 µl 
MgCl2      : 3 µl 
Taq DNA polymerase   : 0.5 µl 
dH2O      : 37 µl 
Total Volume     : 50 µl 
 Reaction Conditions                                                             
 
95°C   4 min 
94°C 1 min 
60°C   1 min              30 cycles 
72°C 1 min   
72°C 20 min 
PCR product was run on 2.5% agarose gel and desired gene product was extracted 
from the gel.      
 Gel Extraction Prosedure 
Gel extraction reactions in this study are performed by MinElute Gel Extraction Kit 
(Catalog # 28604, Qiagen).  
1. DNA fragment was excised from agarose gel with a clean scalpel. Gel slices 
were put into microfuge tubes and their weight was calculated.  
2. A 3-gel volume of QG buffer was added to 1 volume of gel slice. (600 µl for 
100 mg gel). When gels were excised from a %2 or more concentrated gel, a 
6-gel volume of QG buffer was applied.  
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3. Sample was incubated at 50oC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture was checked. QG 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the 
optimum pH for DNA adsorption. If the color of the mixture was not yellow, 
10 µl of 3 M sodium acetate, pH5.0 was added. 
5. After the gel dissolved, 1 gel volume of room temperature 100% isoproponal 
was added and mixed by inverting the tube several times. 
6. Sample was applied to the MinElute column and centrifuged for 1 min. at 
13000 rpm. 
7. Flow-trough was discarded from collection tube. 
8. 500 µl QG buffer was applied to column and centrifuged for 1 min. at 13000 
rpm. 
9. Flow-trough was discarded from collection tube. 
10. In order to wash, 750 µl PE buffer was applied to the column and centrifuged 
for 1 min. at 13000 rpm. 
11. Flow-through was discarded from collection tube and centrifuged for an 
additional 1 min. 
12. Spin column was placed in a microfuge and 10 µl EB buffer was applied to 
elute the DNA. After 1 min. incubation the tube was centrifuged for 1 min. 
Eluted DNA is stored at –4oC prior to usage or at –20oC for long term storage. 
2.2.1.2. Cloning into a TA Vector 
TA cloning vectors contain a U overhang at each ends providing easy and efficient 
ligaton of PCR products with an A overhang. Unpaired A residues are added to PCR 
products during PCR reactions generated by Taq DNA polymerase. Hence the DNA 
obtained from PCR was gel extracted and used directly to be cloned into pCR2.1-
TOPO TA Cloning Vector. 
Ligation reaction was performed according to TOPO TA Cloning
®
 Kit (Catalog # K 
4500-01, Invitrogen). 
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 Ligation Reaction 
Fresh PCR product    : 2 µl  
Salt Solution     : 1 µl  
Water     : 2 µl   
TOPO
®
 vector    : 1 µl  
Final Volume    : 6 µl 
The reaction was mixed gently and incubated for 15 minutes at room temperature 
(22-23°C). The reaction was placed on ice and proceeded to transformation. 
 Chemical Transformation Procedure  
1. 2 µl of the TOPO cloning reaction was added into a vial of One Shot DH5α-
T1 chemically competent E. coli and mixed gently. 
2. Incubated on ice for 15 minutes. 
3. Heat-shock was applied to the cells for 30 seconds at 42°C without 
shaking.   
4. The tubes were transferred immediately to ice.   
5. 250 µl of room temperature S.O.C. medium was added.   
6. The tube was capped tightly and shaken horizontally (200 rpm) at 37°C for 
1 hour. 
7. During the incubation of cells Xgal/IPTG-Amp plates were prepared. 50 µl 
Xgal/IPTG and 100 µl ampicillin were put into 50 mL liquid warm LB agar 
and it was poured onto plastic sterile petri plates. 
8. After incubation 50, 100 and 150 µl serial dilutions of transformation 
mixture were spread on prewarmed Xgal/IPTG-Amp LB agar plates. 
9. Plates were incubated overnight at 37°C.  
2.2.1.3. Plasmid Purification 
White colonies obtained subsequent to transformation were selected and incubated 
overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 l of this bacterial 
culture was mixed with 300 l 50% glycerol and stored at –80oC. Plasmid DNA was 
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purified from 4 mL bacterial culture for sequencing and further applications by High 
Pure Plasmid Isolation Kit (Catalog # 11 754 785 001, Roche). Procedure is 
described in detail below. 
1. 4 mL bacterial culture was divided into two 2 mL microfuge tubes and 
centrifuged in a standard bench-top microcentrifuge at 6 000 x g for 1 minute. 
The supernatant was discarded. 
2. 250 µl Suspension Buffer containing RNase was added to each microfuge 
tube containing the bacterial pellet. The bacterial pellet was resuspended and 
mixed well. 
3. 250 µl Lysis Buffer was added to the resuspended bacterial pellet and mixed 
gently by inverting the tube 3 to 6 times. The tube was incubated for 5 min at 
room temperature (25°C). 
4. 350 µl chilled Binding Buffer was added to the lysed solution and mixed 
gently by inverting the tube 3 to 6 times. Incubated on ice for 5 min. 
5. Centrifuged for 10 min at approximately 13 000 x g (full speed) in a standard 
tabletop microcentrifuge. 
6. After centrifugation one High Pure Filter Tube was inserted into one 
Collection Tube. The entire entire supernatant from Step 5 was transferred 
into upper buffer reservoir of the Filter Tube. The entire High Pure Tube 
assembly was inserted into a standard tabletop microcentrifuge and 
centrifuged for 1 min at 13 000 x g. 
7. After centrifugation the Filter Tube was removed from the Collection Tube, 
the flowthrough liquid was discarded, and the Filter Tube was reinserted in 
the same Collection Tube. 
8. To wash the cells 700 µl Wash Buffer II was added to the upper reservoir of 
the Filter Tube and centrifuged for 1 min at 13 000 x g in a standard tabletop 
microcentrifuge. 
9. After discarding the flowthrough liquid the entire High Pure Tube assembly 
was centrifuged for an additional 1 min to remove residual Wash Buffer. The 
collection tube was discarded. 
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10. To elute the DNA the Filter Tube was inserted into a clean, sterile 1.5 ml 
microcentrifuge tube. 100 µl Elution Buffer or double distilled water (pH 
adjusted to 8.0 – 8.5) was added to the upper reservoir of the Filter Tube. The 
tube assembly was centrifuged for 1 min at 13 000 x g in a standard tabletop 
microcentrifuge. 
11. The microcentrifuge tube containing the eluted plasmid DNA was either used 
directly in applications such as cloning or sequencing or stored at –20°C for 
later analysis.        
2.2.1.4. Plasmid DNA Sequencing 
Ready Reaction Mix*    2 µl 
BigDye Terminator Sequencing Buffer (5X)* 1 µl 
Template dsDNA      1 µl (80ng) 
M13 –20 Forward Primer    1 µl (3.2 pmole) 
dH2O       5 µl 
Total volume      10 µl 
*BigDye
®
 Terminator v3.1 Cycle Sequencing Kit from Applied Biosystems. 
 Reaction conditions 
95
o
C   5’ 
95
o
C   30” 
60
o
C  30”                                                    35 cycles
72
o
C  2’ 
72
o
C  5’ 
4
o
C  ∞ 
 Purification of PCR products  
Sodium acetate-Ethanol precipitation was applied to the PCR products before 
sequence analysis. 
1. 1 µl 3M pH 4.6 sodium acetate and 25 µl 95 % ethanol were mixed for each 
sample. 
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2. 26 µl mixture was added into each PCR product and samples were incubated 
on ice for 15 min. 
3. After incubation, samples were centrifuged for 15 min at 14000 rpm. 
4. Supernatant was discarded and DNA pellet was washed with 250 µl cold 70% 
ethanol. 
5. Samples were centrifuged for 15 min at 14000 rpm. 
6. Ethanol was discarded and samples were incubated for 5 min at 95oC for the 
evaporation of all residual ethanol. 
7. DNA was dissolved in 20 µl Hi-Di Formamide. 
8. Samples were denatured by first putting at 95oC for 5 min and then at -20oC. 
ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was used for 
DNA sequencing.   
2.2.1.5. Cloning into pETBlue-2 Expression Vector 
pCR2.1-TOPO TA cloning vector was digested with restriction enzymes and desired 
DNA fragment was gel extracted. Insert DNA which was cleaned and concentrated 
was ligated into pETBlue-2 expression vector. Procedure is described in detail 
below. 
 Restriction Enzyme Digestion  
6xHis-Linker sequence was double digested with BglII and EcoRI restriction 
enzymes from pCR2.1-TOPO TA cloning vector. In order to obtain the sequence in 
high DNA concentration 16 reaction were performed. The digested sequence was 
extracted from the gel. 
 Digestion of pCR2.1-TOPO TA Vector 
pCR2.1-TOPO-6xHis-Linker  10 µl (1.2 µg) 
Buffer Orange     2 µl 
BglII (5U)     0.5 µl 
EcoRI (5U)     0.5 µl 
Sterile dH2O     7 µl 
Total Volume     20µl           x        16 reactions 
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 Reaction conditions 
The reactions were incubated at 37°C for 4 hours and 15 minutes at 65C for enzyme 
inactivation. Digestion reactions were run on 2.5% agarose gel electrophoresis and 
the desired 107 bp 6xHis-Linker sequence was extracted from the gel according to 
previously described procedure. 
 Digestion of pETBlue-2 Expression Vector 
pETBlue-2 expression vector was double digested with BglII and EcoRI restriction 
enzymes.  
pETBlue-2      1.5 µl (750ng) 
BglII (5U)     0.4 µl 
EcoRI (5U)     0.4 µl 
Buffer Orange     1 µl 
Sterile dH2O     6.7 µl 
Total Volume     10µl  
 Reaction conditions 
The reaction was incubated at 37°C for 2.5 hours and 15 minutes at 65°C for enzyme 
inactivation. Digestion reaction was run on 1% agarose gel electrophoresis and the 
digested vector was extracted from the gel according to previously described 
procedure. 
 Ligation into pETBlue-2 Vector 
Ligation reaction was performed with Quick Ligation™ Kit (New Enland Biolabs, 
Inc., Catalog # M2200S) 
1. 1 µl (60 ng) pETBlue-2 vector was combined with 1 µl (5 ng) of 
insert (3-fold molar excess). Volume was adjusted to 10 µl with 
dH2O. 
2. 10 µl of 2X Quick Ligation Buffer was added and mixed. 
3. 1 µl of Quick T4 DNA Ligase was added and mixed thoroughly. 
4. Centrifuged briefly and incubated at room temperature (25°C) for 15 
minutes. 
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5. Chilled on ice and transformed or stored at –20°C for longer storage. 
6. It was not heat inactivated bacause heat inactivation dramatically 
reduces transformation efficiency.   
 Transformation Procedure for pETBlue-2 
3 µl of the ligation reaction was transformed into a vial of One Shot TOP10 
chemically competent E. coli cells as previously described. Plates were incubated 
overnight at 37°C.  
White colonies obtained subsequent to transformation were selected and incubated 
overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 l of this bacterial 
culture was mixed with 300 l 50% glycerol and stored at –80oC. Plasmid DNA was 
purified from 4 mL bacterial culture for sequencing and further applications by High 
Pure Plasmid Isolation Kit as previously described. 
 Plasmid DNA Sequencing 
Ready Reaction Mix*    2 µl 
BigDye Terminator Sequencing Buffer (5X)* 2 µl 
Template dsDNA      1 µl (70ng) 
pETBlue-2 Up Primer    1 µl (3.2 pmole) 
dH2O       4 µl 
Total volume      10 µl 
*BigDye
®
 Terminator v3.1 Cycle Sequencing Kit from Applied Biosystems. 
 Reaction conditions 
95
o
C   5’ 
95
o
C   1’ 
50
o
C  30”                                                    35 cycles
60
o
C  4’ 
4
o
C  ∞ 
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Sodium acetate-Ethanol precipitation was applied to the PCR products before 
sequence analysis as previously described. ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer was used for DNA sequencing. 
2.2.2. Construction of pETBlue-2-GFPuv Vector 
Two primers were designed for the amplification of Green Fluorescent Protein 
(GFPuv) with PCR. The primers have flanking regions which contain restriction 
sites. Forward primer contains EcoRI restriction site and Reverse primer contains 
PstI restriction site. The primers were synthesized and obtained from Alpha DNA, 
Montreal (Quebec). The gene product GFPuv, obtained from PCR, is ligated into 
pCR2.1-TOPO cloning vector and transformed into E. coli DH5α-T1 chemically 
competent cells. GFPuv sequence was double digested with EcoRI and PstI 
restriction enzymes from TOPO-TA vector and gel extracted. Than pETBlue-2-
6xHisLinker construct was double digested with EcoRI and PstI restriction enzymes 
and reaction cleaned up. The digested vector was used to insert GFPuv sequence 
adjacent to 6xHisLinker in order to obtain the complete construct namely pETBlue-
2-GFPuv. The vector pETBlue-2-GFPuv is transformed into E. coli Tuner (DE3) 
pLacI chemically competent cells. Each step is discussed below in detail. 
2.2.2.1 Amplification of GFPuv 
Polymerase chain reaction (PCR) was obtained with GFPuv forward and GFPuv 
reverse primers in order to amplify GFPuv gene with appropriate restriction 
enzymes. Reaction conditions are described below: 
 Polymerase Chain Reaction (PCR) 
Template DNA (pGFPuv)   : 0.5 µl (50 pmol) 
GFPuv Forward Primer   : 1 µl (10 pmol) 
GFPuv Reverse Primer   : 1 µl (10 pmol) 
dNTP (2.5 mM each)    : 4 µl 
Pfu Buffer with MgSO4 (10X)  : 5 µl 
Pfu DNA polymerase    : 0.5 µl 
dH2O      : 38 µl 
Total Volume     : 50 µl 
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 Reaction Conditions                                                             
 
95°C   5 min 
95°C 1 min 
60°C   1 min              30 cycles 
72°C 2 min   
72°C 10 min 
PCR product was run on 1% agarose gel and desired gene product was extracted 
from the gel as previously described. 
2.2.2.2. Cloning into a TA Vector 
TA cloning vectors contain a U overhang at each ends providing easy and efficient 
ligaton of PCR products with an A overhang. However, PCR products generated 
using proofreading DNA polymerases, such as Pfu  DNA Polymerase are blunt-
ended and cannot be used directly in UA- or TA-cloning procedures. These PCR 
products are cloned combined with an A-Addition procedure which allows fast and 
efficient modification of the 3' end of blunt PCR products. Modified PCR products 
containing an A overhang were cloned into pCR2.1-TOPO TA Cloning Vector.    
 A-Addition Reaction 
PCR product (gel extracted GFPuv)  8 μl (400 ng.) 
5X A-Addition master mix   2 μl 
Total volume     10 μl 
QIAGEN® A-Addition Kit (Catalog # 231994, Qiagen)  
 Ligation Reaction 
TOPO
®
 vector*    : 1 µl  
A-Addition reaction  : 3 µl  
Salt Solution*   : 1 µl  
Water     : 1 µl   
Final Volume    : 6 µl 
* TOPO TA Cloning
®
 Kit (Catalog # K 4500-01, Invitrogen) 
Incubated for 30 
minutes at 37
o
C.  
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 Reaction conditions 
The reaction was mixed gently and incubated for 15 minutes at room temperature 
(22-23°C).  
The ligation reaction was transformed into One Shot DH5α-T1 chemically competent 
E. coli cells as previously described.  
White colonies obtained subsequent to transformation were selected and incubated 
overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 l of this bacterial 
culture was mixed with 300 l 50% glycerol and stored at –80oC. Plasmid DNA was 
purified from 4 mL bacterial culture by High Pure Plasmid Isolation Kit (Catalog # 
11 754 785 001, Roche) as previously described. 
Purified plasmids were sequenced with ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer as previously described.  
2.2.2.3. Cloning into pETBlue-2-6xHisLinker Vector 
pCR2.1-TOPO TA cloning vector was digested with restriction enzymes and desired 
DNA fragment was gel extracted. Insert DNA which was cleaned and concentrated 
was ligated into pETBlue-2 expression vector. Procedure is described in detail 
below. 
 Restriction Enzyme Digestion 
GFPuv sequence was double digested with EcoRI and PstI restriction enzymes from 
pCR2.1-TOPO TA cloning vector. The digested sequence was extracted from the gel 
as previously described. 
 Digestion of pCR2.1-TOPO-GFPuv Vector 
pCR2.1-TOPO-GFPuv   12 µl (1 µg) 
10X Buffer Orange     2 µl 
EcoRI       1 µl (10U) 
PstI      1 µl (10U) 
Sterile dH2O     4 µl 
Total Volume     20µl           x        2 reactions 
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 Reaction conditions 
The reactions were incubated at 37°C for 2.5 hours and 30 minutes. Digestion 
reactions were run on 1% agarose gel electrophoresis and the desired 735 bp GFPuv 
sequence was extracted from the gel according to previously described procedure. 
 Digestion of pETBlue-2-6xHisLinker Vector 
pETBlue-2-6xHisLinker expression vector was first digested with EcoRI and than 
digested with PstI restriction enzymes separately.  
pETBlue-2-6xHisLinker    15 µl (750ng) 
EcoRI      1 µl 
EcoRI Buffer 10X     2 µl 
Sterile dH2O     2 µl 
Total Volume     20µl   x   2 reactions 
 Reaction conditions 
The reaction was incubated at 37°C for 5 hours. Digestion reaction was reaction 
cleaned up.   
 Reaction Clean Up Prosedure 
Reaction clean up prosedure is performed by MinElute Reaction Cleanup Kit 
(Catalog # 28206, Qiagen). 
1. 300 µl of Buffer ERC was added to the enzymatic reaction and mixed.  
2. The color of the mixture was checked if it is yellow (similar to Buffer ERC 
without the enzymatic reaction). If the color of the mixture was orange or 
violet, 10 µl of 3 M sodium acetate, pH 5.0, was added and mixed. The color 
of the mixture was turned to yellow. 
3. A MinElute column was placed in a 2 ml collection tube in a suitable rack. 
4. To bind DNA, the sample was applied to the MinElute column and 
centrifuged for 1 min at 13,000 rpm. 
5. The flow-through was discarded and the MinElute column was placed back 
into the same tube. 
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6. To wash, 750 µl Buffer PE was added to the MinElute column and 
centrifuged for 1 min at 13,000 rpm. 
7. The flow-through was discarded and the MinElute column was placed back in 
the same tube. The column was centrifuged for an additional 1 min at 
maximum speed to remove residual ethanol completely. 
8. The MinElute column was placed in a clean 1.5 ml microcentrifuge tube. 
9. To elute DNA, 10 µl Buffer EB (10 mM Tris·Cl, pH 8.5) or H2O was added 
to the center of the membrane, let the column stand for 1 min, and then 
centrifuged for 1 min at 13,000 rpm. 
10. Eluted DNA was stored at -20°C. 
 Digestion of pETBlue-2-6xHisLinker Vector 
pETBlue-2-6xHisLinker    10 µl  
PstI      1 µl (10U) 
Buffer Orange 10X     1.5 µl 
Sterile dH2O     2.5 µl 
Total Volume     15µl 
 Reaction conditions 
The reaction was incubated at 37°C for 2.5 hours and 15 minutes at 65°C for enzyme 
inactivation. Digestion reaction was run on 1% agarose gel electrophoresis and the 
digested vector was extracted from the gel as previously described. 
 Ligation into pETBlue-2-6xHisLinker Vector 
Ligation reaction was performed with Quick Ligation™ Kit (New Enland Biolabs, 
Inc., Catalog # M2200S) 
1. 1 µl (60 ng) pETBlue-2-6xHisLinker vector was combined with 1.5 µl 
(30 ng) of insert (3-fold molar excess). Volume was adjusted to 10 µl 
with dH2O. 
2. 10 µl of 2X Quick Ligation Buffer was added and mixed. 
3. 1 µl of Quick T4 DNA Ligase was added and mixed thoroughly. 
  
34 
4. Centrifuged briefly and incubated at room temperature (25°C) for 15 
minutes. 
5. Chilled on ice and transformed or stored at –20°C for longer storage. 
6. It was not heat inactivated bacause heat inactivation dramatically 
reduces transformation efficiency.   
 Electrotransformation Procedure for pETBlue-2 
1. 5 µl of the ligation reaction was added into a vial of One Shot TOP10 
electrocompetent E. coli and mixed gently.  
2. Solution was carefully transferred to a 0.1 cm cuvette to avoid 
formation of bubbles. 
3. Sample was electroporated at 1800 Volts for 2-3 seconds in 
electroporator.   
4. Immediately 250 µl of room temperature S.O.C. medium was added. 
5. The solution was transferred to a 1.5 ml microcentrifuge tube and 
shaken for 1 hour at 37°C to allow expression of the antibiotic 
resistance genes. 
6. 50-100 µl was spread from transformation on a prewarmed 
Xgal/IPTG-Amp plates and incubated overnight at 37°C.   
Light blue or white colonies obtained subsequent to transformation were selected and 
incubated overnight in 5 mL LB containing 100 µg/mL ampicillin. 700 l of this 
bacterial culture was mixed with 300 l 50% glycerol and stored at –80oC. Plasmid 
DNA was purified from 4 mL bacterial culture for sequencing and further 
applications by High Pure Plasmid Isolation Kit as previously described. 
Purified plasmids were sequenced with ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer as previously described.  
2.2.2.4. Competent Cell Preparation  
1. Single line of colony of E. coli Tuner (DE3) pLacI was inoculated to 10 ml 
LB liquid medium and incubated overnight at 37
o
C and 250 rpm.  
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2. 1 ml of overnight culture was inoculated into 100 ml of LB liquid medium 
and incubated at 37
o
C, 250 rpm until optical density reached 0.4 at 600 nm 
(OD600). 
3. The culture was transferred into a 250 ml Beckman centrifuge tube and kept 
on ice for 20 minutes.  
4. The tube was centrifuged for 10 minutes at 3000x g, 4oC in Beckman Coulter 
Avanti J-30I centrifuge.  
5. The supernatant was discarded. The pellet was gently resuspended in ice-cold 
12 ml 0.1 M CaCl2 solution and kept on ice for 30 minutes. 
6. The tube was centrifuged for 10 minutes at 3000x g, 4oC and the supernatant 
was discarded. 
7. The pellet was gently resuspended in ice-cold 3 ml 0.1 M CaCl2 solution and 
15 % Glycerol (w/v) and kept on ice for 10 minutes. 
8. 50 µl aliquots of the cells were taken into1.5 ml microcentrifuge tubes and 
stored at -80
o
C. 
2.2.2.5. Transformation of pETBlue-2-GFPuv Vector into Host Strain Tuner 
(DE3) pLacI 
1. 1 µl of pETBlue-2-GFPuv vector (50 ng) was added into a vial of Tuner 
(DE3) pLacI chemically competent E. coli host strain and mixed gently. 
2. Incubated on ice for 10 minutes. 
3. Heat-shock was applied to the cells for 30 seconds at 42°C without 
shaking.   
4. The tube was transferred immediately on ice and kept for 2 minutes.   
5. 100 µl of room temperature S.O.C. medium was added.   
6. The tube was capped tightly and shaken horizontally (250 rpm) at 37°C for 
1 hour. 
7. LB agar plates containing Ampicillin and Chloramphenicol were prepared. 
25 µl Ampicillin and 50 µl Chloramphenicol were put into 50 mL liquid 
warm LB agar and it was poured onto plastic sterile petri plates. 
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8. After incubation transformation mixture was spread on prewarme Amp-Cam 
LB agar plates. 
9. Plates were incubated overnight at 37°C.  
2.2.3. Protein Expression Analysis 
It is important to determine whether the protein is soluble in the cytoplasm or located 
in cytoplasmic inclusion bodies to set up the best purification strategy. Many 
proteins, when they are expressed at high levels in bacteria, form inclusion bodies 
while others are tolerated well by the cell and remain in the cytoplasm in their native 
configuration. 
2.2.3.1. Determination of Target Protein Solubility 
1. A single colony from a freshly streaked plates from glycerol stocks of Tuner 
(DE3) PlacI harboring pETBlue-2-GFPuv or pETBlue-2 were picked up and 
inoculated into 5 ml LB medium containing 50μg/ml ampicillin and 34µg/ml 
chloramphenicol in 50 ml Falcon tube to analyze the target protein production 
and its solubility. Culture was grown overnight at 37°C or 30°C with shaking 
at 250 rpm. 
2. 50 ml pre-warmed LB containing 50 μg/ml ampicillin and 34µg/ml 
chloramphenicol was inoculated with 0.5 ml of the overnight culture and 
grown at 37°C or 30°C with vigorous shaking (250 rpm) until the OD600 was 
0.5-0.8.   
3. 1 ml sample was taken immediately before induction (noninduced control). 
The cells were centrifuged at 14.000 rpm and the pellet was resuspended in 
50 μl 1xSDS-PAGE sample buffer. The sample was frozen at –20°C until 
needed for SDS-PAGE.  
4. Cells were induced with 0.1-1.0 mM IPTG and incubated for 3 to 12 hours at 
37°C or 30°C. 
5. 1 ml sample (induced control) was taken each hour and centrifuged. Pellets 
were resuspended in 100 μl 1x SDS-PAGE sample buffer and frozen at –
20°C until needed for SDS-PAGE. 
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6. Cells were harvested by centrifugation at 4 000 x g for 20 min. Cell pellet 
was resuspended in 50 µl of lysis buffer and 3 µl of lysozyme (25 mg/ml) 
was added to the sample.   
7. Cell lysate was sonicated 6 x 10 s with 10 s pauses at 400 W on ice. Lysate 
was centrifuged at 10 000 x g at 4°C for 25 min. The supernatant was 
decanted (soluble protein) and saved on ice. 
8. The pellet was resuspended in 50 µl of lysis buffer which constitutes the 
suspension of insoluble matter (insoluble protein). 
9. 50 μl of 2xSDS-PAGE sample buffer was added to each of the soluble 
protein and insoluble protein extract. 
10. Samples were heated with the frozen noninduced and induced cell samples at 
95°C for 5 min. 
11. Induced, non-induced and 2.5 ml of soluble protein mixtures were 
centrifuged at 15.000 x g for 1 min. All the samples were stored at –20°C 
until SDS-PAGE analysis.   
2.2.3.2. SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electro-
phoresis) 
Sodium dodecyl  sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run as 
described before by (Laemmli et al., 1970) using vertical gel electrophoresis system. 
It was stained for 30 minutes in CBB-R250 stain solution for 30 min in room 
temperature on rocker at 15 rpm. It was destained in destain solution for overnight on 
rocker at 15 rpm in room temperature. Solutions for preparing resolving gels are and 
their buffers are mentioned below: 
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All the solutions in table 2.1 were mixed to prepare 12% resolving gels for SDS-
PAGE.  
Table 2.1: Components of 12% separating gel for SDS-PAGE 
Components Amount (1%2) 
30% acrylamide mix 2 ml 
Tris (Hydroxymethyl) aminomethane (Tris) (1.5M, pH 8.8) 1.3ml  
10% APS 50 μl 
10% Sodium n-Dodecyl Sulfate (SDS) 50 μl 
N,N,N’,N’-Tetraethyl ethylenediamine (TEMED) 2 μl 
dH2O 1.6 ml 
Total Volume 5 ml 
 
All the solutions in table 2.2 were mixed to prepare 5% Stacking Gels for SDS-
PAGE. 
Table 2.2: Components of 5% stacking gel for SDS-PAGE 
Components Amount (5%) 
30% acrylamide mix 0.33 ml 
Tris (Hydroxymethyl) aminomethane (Tris) (1M, pH 8.8) 0.25ml  
10% APS 20 μl 
10% Sodium n-Dodecyl Sulfate (SDS) 20 μl 
N,N,N’,N’-Tetraethyl ethylenediamine (TEMED) 2 μl 
dH2O 1.4 ml 
Total Volume 2 ml 
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All the components in table 2.3 were mixed and then filtered through 
chromatography paper. 
Table 2.3: Components of CBB -R250 stain solution. 
Components Amount 
dH2O 450 ml 
Methanol 450 ml 
Acetic acid 100 ml 
0.2% g/ml CBB-R250 in dH2O 2 ml 
Total 1002 ml 
 
All the components in table 2.4 were mixed to form the destain solution. 
Table 2.4: Components of destain solution. 
Components Amount 
dH2O 800 ml 
Methanol 100 ml 
Acetic acid 100 ml 
Total 1000 ml 
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3. RESULTS AND DISCUSSION 
3.1. Construction of His-Tagged GFPuv Vector 
3.1.1. Cloning of 6xHis-Linker Sequence into pETBlue-2 Expression Vector  
In order to obtain His-taged GFPuv construct on pETBlue-2 expression vector, first 
of all 6xHis-Linker sequence was cloned into the vector. Initially 6xHis-Linker 
sequence was amplified by using PCR. The synthesized 131 bp oligonucleotide was 
used as a template. The oligonucleotide includes restriction endonucleases BglII and 
EcoRI nearer the ends and BamHI between 6xHis tag and spacer. Forward and 
reverse primers were used in order to amplify and obtain double-stranded 6xHis-
Linker sequence from a single stranded oligonucleotide. Besides, BglII and EcoRI 
restriction sites were obtained at each end. Agarose gel electrophoresis of the PCR 
product is shown in figure 3.1. 
     1              2               3                                                  M10       
                               
Figure 3.1: 2.5% agarose gel of PCR reaction. Lane 1: Marker 10, PhiX174 DNA/HinfI 
Marker, Lane 2: PCR product obtained from Tm = 58°C reaction, Lane 3: PCR product 
obtained from Tm = 60°C reaction. 
It is observed that 60°C annealing gives a better band than 58°C. So another PCR 
reaction was done at 60°C annealing temperature in order to obtain DNA in large 
quantities. The required 131 bp band was gel extracted in order to get rid of 
131 bp 
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nonspecific sequences. By obtaining the desired DNA fragment on agarose gel, the 
extracted PCR product was cloned into pCR2.1-TOPO cloning vector. The vector 
was than transformed into DH5α-T1 chemically competent E. coli cells. pCR2.1-
TOPO is a TA cloning vector that needs unpaired Adenine residues on 3'-ends of the 
DNA fragment to be inserted. Taq DNA polymerase adds Adenine residues to 3'-
ends of amplified DNA sequence with a longer final extension step during PCR. 
Therefore 6xHis-Linker sequence, which is amplified by PCR and Adenine residues 
were added to 3'-ends with Taq DNA polymerase, was easily cloned into pCR2.1-
TOPO TA cloning vector. 24 white colonies obtained from transformation were 
amplified and their plasmids were isolated. The DNA sequence of the resulting 
plasmids was verified by DNA sequence analysis. The plasmids which bear 6xHis-
Linker sequence were used to amplify the insert to have a required amount for 
ligation into expression vector.  
 M10         6xHis-Linker                                M10 
               
Figure 3.2: 2.5% agarose gel electrophoresis. Lane 1: Marker 10, PhiX174 DNA/HinfI 
Marker, Lane 2: 6xHis-Linker fragment obtained after BglII and EcoRI digestion of the 
pCR2.1-TOPO TA vector and gel extracted.  
pCR2.1-TOPO TA vector which contains the desired insert 6xHis-Linker sequence 
was amplified and purified. The vector was double digested with BglII and EcoRI 
restriction enzymes in order to obtain the insert. Digestion reaction was run on 2.5% 
agarose gel and the resulting desired 109 bp fragment (6xHis-Linker, insert) was gel 
extracted (Figure 3.2.). 
109 bp 
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Simultaneously pETBlue-2 expression vector was also digested with the same 
enzymes BglII and EcoRI and gel extracted (Figure 3.3). The digested 6xHis-Linker 
DNA fragment was ligated into pETBlue-2 expression vector. The ligation reaction 
was transformed into TOP10 chemically competent E. coli cells. Obtained white 
colonies were selected and grown in LB broth medium and plasmids DNA of the 
colonies were purified. Plasmid DNAs were sequenced and 6xHis-Linker insertion in 
pETBlue-2 expression vector was obtained (See Appendix D).  
                  Single      Double 
   Uncut     digest       digest        M3                       M3 
                                 
Figure 3.3: 1% agarose gel electrophoresis. Lane 1: Uncut pETBlue-2 expression vector, 
Lane 2: EcoRI digested pETBlue-2 expression vector, Lane 3: BglII and EcoRI digested 
pETBlue-2 expression vector, Lane 4: Marker 3, Lambda DNA/ EcoRI+HindIII. 
 
3.1.2. Cloning of GFPuv Gene into pETBlue-2 Expression Vector    
With the purpose of obtaining 6xHis-Linker-GFPuv construct on petBlue-2 
expression vector, cloning of the GFPuv sequence was attained afterward. First of 
all, GFPuv sequence which is 731 bp was amplified via PCR by using pGFPuv 
plasmid as a template. During PCR reaction, EcoRI restriction site was introduced 
with forward primer and PstI restriction site was introduced with reverse primer to 
the PCR products. Amplification of GFPuv with PCR was applied by using a 
proofreading polymerase that is Pfu DNA polymerase (Figure 3.4 A). PCR products 
generated using proofreading DNA polymerases are blunt-ended and cannot be used 
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directly in UA- or TA-cloning procedures. So the obtained PCR products were 
cloned combined with an A-Addition procedure which allows fast and efficient 
modification of the 3' end of blunt PCR products.  
 
Figure 3.4 1% agarose gel electrophoresis. A. M3, Marker-3 Lambda DNA/ EcoRI+HindIII 
marker, PCR amplified GFPuv. B. GFPuv fragment obtained after EcoRI and PstI digestion 
of the pCR2.1-TOPO TA vector and gel extracted; M3: Marker-3 Lambda DNA/ 
EcoRI+HindIII marker.     
Modified PCR products (GFPuv) containing A overhangs were ligated into pCR2.1-
TOPO TA cloning vector and transformed into E. coli DH5α-T1 chemically 
competent cells. Obtained white colonies from transformation were amplified and 
their plasmids were isolated. The DNA sequence of the resulting plasmids was 
verified by DNA sequence analysis. The plasmids which bear GFPuv sequence were 
used to amplify the insert to have a required amount for ligation into expression 
vector.       
pCR2.1-TOPO TA vector which contains the desired insert GFPuv sequence was 
amplified and purified. GFPuv sequence was double digested with EcoRI and PstI 
restriction enzymes from the cloning vector and gel extracted. Digestion reaction was 
run on 1% agarose gel and the resulting desired 731 bp fragment (GFPuv, insert) was 
gel extracted (Figure 3.4 B).  
M3 M3 
  
44 
At the same time pETBlue-2 expression vector which contains 6xHis-Linker insert 
was digested with the enzymes EcoRI / PstI and reaction cleaned up (Figure 3.5). 
The digested vector was used to insert GFPuv sequence adjacent to 6xHis-Linker in 
order to obtain the complete construct namely pETBlue-2-GFPuv. The vector 
pETBlue-2-GFPuv is transformed into TOP10 electrocompetent E. coli cells.                                                      
  
                            Double 
                          M3   digest   Uncut 
                                                             
Figure 3.5 1% agarose gel electrophoresis. Lane 1: M3, Lambda DNA/ EcoRI+HindIII 
marker; Lane 2: EcoRI and PstI digested pETBlue-2-6xHis-Linker vector; Lane 3: Uncut 
pETBlue-2-6xHis-Linker vector.  
Obtained white colonies were selected and grown in LB broth medium and plasmids 
DNA of the colonies were purified. Plasmid DNAs were sequenced and GFPuv 
insertion in pETBlue-2 expression vector adjacent to 6xHis-Linker sequence was 
obtained (See Appendix E). After the sequence of the construct was verified that 
contain both 6xHis-Linker sequence and GFPuv gene, the plasmid was transformed 
into host strain E. coli Tuner (DE3) pLacI chemically competent cells for the 
expression of His-Tagged GFPuv. 
3.2. Protein Expression Analysis 
Generally expression of recombinant proteins is advanced by starting with a plasmid 
that encodes the desired protein and introducing the plasmid into the required host 
cell. Afterward the host cells are grown and expression is induced followed by cell 
lysis and SDS-PAGE analysis to verify the presence of the protein. Most 
recombinant proteins can be cloned and expressed at high levels in E. coli with 
careful choice of host strains, vectors, and growth conditions. On the other hand 
many polypeptide gene products expressed in E. coli may lack functional activity as 
they can accumulate as insoluble aggregates. Other problems with protein expression 
M3 
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may include cell toxicity, protein instability, improper processing and inefficient 
translation.       
Experimental purpose for which the protein will be utilized is the primary 
consideration for recombinant protein expression and purification. It is often 
important to optimize conditions for the expression of soluble, functionally active 
protein for biochemical and structural studies. Freshly transformed bacterial colonies 
often express recombinant proteins at different levels so conditions for optimal 
expression of individual proteins must be determined empirically. Before large-scale 
protein purification is considered the optimal growth and expression conditions for 
the protein of interest should be established with small-scale cultures. Especially 
before cell growth and after induction of expression should be monitored so as to 
judge the toxicity of an expressed protein. When a slower growth rate is established 
with the host cells expressing the protein of interest it is the indication of the gene 
product that may be toxic to the E. coli host. On the contrary, faster growth rate may 
point to inefficient transcription or translation due to plasmid instability, inefficient 
induction, or deletions in the control region [61].              
In order to determine whether the protein is soluble in the cytoplasm or located in 
cytoplasmic inclusion bodies protein expression analysis were performed. The 
bacterial strain which harbours pETBlue-2 vector was used as the negative control. 
Also uninduced cultures were analysed via SDS-PAGE as a control of induced 
cultures. Same volume amounts of starting culture were used for induction in order 
to prevent optical density differences. Cells were grown in LB broth medium at 37°C 
or 30°C until OD600 reached 0.7. The cultures were induced with 0.1 mM to 1mM 
IPTG and incubated for 3 to 12 hours. SDS-PAGE soluble fraction analysis of Tuner 
(DE3)placI E. coli strain harbouring pETBlue-2-GFPuv plasmid induced with 0,1-
1,0 mM IPTG at OD600=0,7 for 6 hours which was cultivated in LB broth at 37ºC is 
shown in figure 3.6.   
SDS-PAGE results obtained from expression and induction analysis exhibits that the 
protein is not expressed in the soluble fraction. As shown in figure 3.6 there are no 
differences established compared to the expression vector without insert. There are 
also no differences between different IPTG concentrations applied. Therefore the 
insoluble fraction was analyzed for target protein expression. SDS-PAGE insoluble 
fraction analysis of Tuner (DE3)placI E. coli strain harbouring pETBlue-2-GFPuv 
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plasmid induced with 0,1-1,0 mM IPTG at OD600=0,7 for 6 hours which was 
cultivated in LB broth at 37ºC is shown in figure 3.7. 
 
                           
Figure 3.6: 12% SDS-PAGE soluble fraction analysis of Tuner (DE3)placI E. coli strain 
harbouring pETBlue-2-GFPuv plasmid induced with 0,1-1,0 mM IPTG at OD600=0,7 for 6 
hours which was cultivated in LB broth at 37ºC. Lane 1: Protein molecular weight marker. 
Lane 2: soluble fraction of induced cells harbouring pETBluıe-2. Lane 3: soluble fraction of 
uninduced cells harbouring pETBlue-2. Lane 4: soluble fraction of uninduced cells 
harbouring pETBlue-2-GFPuv. Lane 5: soluble fraction of cells harbouring pETBlue-2-
GFPuv induced with 0,1 mM IPTG. Lane 6: soluble fraction of cells harbouring pETBlue-2-
GFPuv induced with 0,3 mM IPTG. Lane 7: soluble fraction of cells harbouring pETBlue-2-
GFPuv induced with 1 mM IPTG. 
Obtained insoluble fraction SDS-PAGE results show that there is a protein band 
around 37-38 kDa in insoluble fraction. The cells express a protein however the 
GFPuv protein in pETBlue-2 vector is expected to be is ~30 kDa.  
Many factors may contribute to difficulties encountered when expressing foreign 
proteins in E. coli. Low-level expression can occur when the protein is toxic or 
unstable, or because the expression construct is not maintained in the cells during 
growth. In some cases, the 5' end of the inserted DNA sequence may encode 
elements that interfere with transcription or translation. Modifications of growth 
media and different host strains may also have an effect on expression. Some gene 
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products that affect the host cell’s growth rate at low concentrations are considered to 
be toxic. The maintenance of cells can be complicated by the fact that the desired 
cells are likely to be outgrown by cells that harbor mutants of the plasmid and do not 
express the toxic protein. Our construct may result in a toxic product so that we are 
incapable of seeing the desired gene product. Another reason may be that our gene is 
poorly expressed and were are unable to detect it in SDS-PAGE.  
 
                 
Figure 3.7: 12% SDS-PAGE insoluble fraction analysis of Tuner (DE3)placI E. coli strain 
harbouring pETBlue-2-GFPuv plasmid induced with 0,1-1,0 mM IPTG at OD600=0,7 for 6 
hours which was cultivated in LB broth at 37ºC. Lane 1: insoluble fraction of induced cells 
harbouring pETBluıe-2. Lane 2: insoluble fraction of uninduced cells harbouring pETBlue-2. 
Lane 3: Protein molecular weight marker. Lane 4: insoluble fraction of uninduced cells 
harbouring pETBlue-2-GFPuv. Lane 5: insoluble fraction of cells harbouring pETBlue-2-
GFPuv induced with 0,1 mM IPTG. Lane 6: insoluble fraction of cells harbouring pETBlue-
2-GFPuv induced with 0,3 mM IPTG. Lane 7: insoluble fraction of cells harbouring 
pETBlue-2-GFPuv induced with 1 mM IPTG. 
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4.  CONCLUSION 
6xHis-Tagged GFPuv was genetically constructed on the expression vector 
pETBlue-2. GFPuv sequence and 6xHis-Linker sequence were both inserted into 
TOPO-TA cloning vector separately. The sequences were than inserted into 
pETBlue-2 expression vector adjacent to each other 6xHis-Linker being at the N-
terminus of GFPuv. Proline and glycine rich linker sequence was generated between 
hexa-histidine and GFPuv sequence. This linker provides a rigid structure between 
GFPuv and hexa-histidine while the protein is bound to a substrate through histidine 
residues.  
Recombinant proteins can be cloned and expressed at high levels in E. coli with 
careful choice of host strains, vectors, and growth conditions. The host cells bearing 
the expression vector pETBlue-2 that contains 6xHis-Tagged GFPuv were grown 
and expression is induced followed by cell lysis and SDS-PAGE analysis to verify 
the presence of the protein. 
The obtained flexible vector system is applicable for changing both 6xHis and bio-
functional protein parts to apply different inorganic binding peptides tagged with 
functional proteins. 6xHis-tag, a common tagging used in the recovery of the 
peptides or proteins is designed and ready to be used for affinity applications 
compared to the engineered quartz binding peptide (QBP) developed in a parallel 
study. Two developed constructs are tested in terms of their binding affinities to their 
substrates Ni-NTA and Silica separately with the ease of GFPuv fluorescence.   
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APPENDIX 
Appendix A. 
Sequence Landmarks of pETBlue-2 Vector  
Element     Position (bp) 
Lac operator     3606–3625 
T7 promoter     1–17 
Lac operator     22–42 
T7 transcription start    18 
Multiple cloning region   276–467 
(Nco I–Pac I) 
His•Tag® coding sequence   437–454 
HSV•Tag® coding sequence  395–430 
LacZ start codon    491 
LacZ α-peptide ORF    57–491 
E. coli promoter    541–569 
F1 origin     1096–1551 
Bla coding sequence    1669–2526 
pUC origin     3206 
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Appendix B. 
Sequence Landmarks of pCR
®
2.1-TOPO
®
 Vector 
Element    Position (bp)  
LacZα fragment    1-547    
M13 reverse priming site   205-221 
Multiple cloning site    234-357 
T7 promoter/priming site   364-383 
M13 Forward (-20) priming site  391-406 
F1 origin     548-985 
Kanamycin resistance ORF   1319-2113 
Ampicillin resistance ORF   2131-2991 
pUC origin     3136-3809 
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Appendix C. 
Molecular Weight Markers 
 
1)       2)                     3)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
1)  ΦX174 DNA HinfI digested marker-10, 2.5% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0261, NBI Fermentas). 
2)  λ DNA EcoRI and HindIII digested marker-3, 1.0% agarose, 0.5µg/lane, 8 cm 
length  gel, 1X TAE, 17V/cm. (Catalog # SM0191, NBI Fermentas). 
3)  ΦX174 DNA BsuRI digested marker-9, 1.7% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0251, NBI Fermentas). 
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Appendix D. 
Sequence results of 6xHis-Linker sequence in the expression vector pETBlue-2 
(shown in red) 
151   GCGTATCGATGGTACCGTCGACGTCCTGCAGGCGCGCCTGTACAGAATTC    200 
                            |||||||||||||||||||||||||||| 
  1                         GTCCTGCAGGCGCGCCTGTACAGAATTC    28 
 
201   CACGGCCTTCAATCGGCGGCGGGCCCGGCGGCGGGCCCGGCGGGCCCGGC    250 
      |||||||||||||||||||||||||||||||||||||||||||||||||| 
 29   CACGGCCTTCAATCGGCGGCGGGCCCGGCGGCGGGCCCGGCGGGCCCGGC    78 
  
251   GGCGGGGATCCGTGATGGTGATGGTGATGCATGGTATATCTCCTTGAAGA    300 
      |||||||||||||||||||||||||||||||||||||||||||||||||| 
 79   GGCGGGGATCCGTGATGGTGATGGTGATGCATGGTATATCTCCTTGAAGA    128 
 
301   TCTCTCGCTGGCCGTCGTTTTACAACGTCGTGACTGGGAGAATCCTGGCG    350 
      ||||||||||||||||||||||||||||||                     
129   TCTCTCGCTGGCCGTCGTTTTACAACGTCG                        158 
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